ASTRAZENECA VACCINE DATA UNDER FIRE

In the 9 February Trends Journal and subsequent issues, we have been reporting on problems associated with the AstraZeneca COVID vaccine. We had noted that Switzerland’s health agency said it would not administer the Oxford/AstraZeneca COVID-19 vaccine because the data “available and evaluated to date [is] not yet sufficient.” 
A number of European countries followed the Swiss, stopping the jab over concerns of adverse effects, namely blood clots. 
Now, there are concerns in the U.S. as well. On 24 March, The Wall Street Journal published an article with the headline:

U.S. Health Officials Raise Concerns Over AstraZeneca Vaccine Data

The independent monitoring board that provided oversight of the safety vaccine trials has revealed that AstraZeneca producers of the vaccine “might have relied on out-of-date information.”
The U.K. drug company, whose net worth according to macrotrends is $132.91 billion, said it would “update” data being questioned for accuracy. According to the Wall Street Journal report:
“The National Institute of Allergy and Infectious Diseases (NIAID) said it had been informed by the independent data-monitoring board working with AstraZeneca on the U.S. trials that the drug company might have used out-of-date information in its public disclosure of the vaccine’s effectiveness…
AstraZeneca PLC said it would update and reissue later this week efficacy data from human trials of its COVID-19 vaccine after U.S. officials took the rare move of publicly questioning their accuracy—the latest misstep by the British drug giant as it struggles to get its shot into American arms.”
The Director of the Institute is Dr. Anthony Fauci, also the lead medical advisor to President Biden, who said last Tuesday he was “kind of stunned” by the questions surrounding the accuracy of AstraZeneca’s data: “Any type of thing like this could, unfortunately, contribute to a lack of confidence in the process.” Dr. Fauci referred to the inaccurate data as an “unforced error.”
A Real Mess
Nature.com reported last Wednesday about concerns over the AstraZeneca vaccine:
“The road keeps getting bumpier for a vaccine that most researchers say is safe and effective and has huge potential to protect large swathes of the world’s population.”
The report quoted Dr. Eric Topol, director of the Scripps Research Translational Institute in La Jolla California, who said, “The world, the species, depends on this vaccine. This is 2.5 billion people’s worth of vaccine.” He added that the questions surrounding AstraZeneca are “a real mess.”
Over 20 million doses of the vaccine have been injected. Many health experts are counting on this particular vaccine because it doesn’t require the complicated and expensive storage requirements of the other vaccines.
As part of the “real mess” surrounding this vaccine, the New Yorker, in an article published last Tuesday titled, “Why There Is So Much Confusion About the AstraZeneca Vaccine?” wrote that AstraZeneca safety trials were questionable:
“Why wouldn’t AstraZeneca have controlled for age in testing two dosing regimens? Because, it turned out, the different levels had not been part of the original study design; the setup was apparently an attempt to make the best of a measuring error late in the production process.
There were other questions about the initial trials. The participants did not seem as representative as they might have been: Why weren’t more elderly people enrolled, or more diverse populations? Why did AstraZeneca make it harder to untangle its data from the outset, by conflating results from different study sites (in the U.K. and Brazil) that dealt with the data in somewhat different ways?”
TRENDPOST: The website EudraVigilance was established in Europe to track adverse side effects from pharmaceutical drugs. According to Global Research, the latest data reported on 13 March revealed 3,964 deaths and 162,610 injuries as a result of the three COVID vaccines: Moderna, Pfizer-BioNtech, and AstraZeneca.
TRENDPOST: Again, while We the People are banned from the mainstream and social media to question the safety and efficacy of the “Operation Warp Speed” vaccine that has not been officially approved by the FDA, only the establishment “experts” are permitted to be heard… and followed.
The Financial Times reported that a group called the “Center for Countering Digital Hate” (CCDH) is “urging” Facebook, Google, and Twitter to deny access to about a dozen individuals critical of the COVID vaccinations, including Robert F. Kennedy Jr.
The most pressure is coming from 12 Democratic state attorneys-general who want social media to curb “anti-vaccine misinformation.” 
Last Thursday, the heads of Facebook, Google, and Twitter appeared before a congressional committee to answer questions about “online extremism and misinformation.”

Comments are closed.

Skip to content